Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, has adapted its laboratories to help in the national and global fight against COVID-19. As a result of the quick mobilization of its teams and resources, Sidra Medicine is one of the fastest private COVID-19 PCR testing centers in Qatar.

Dr. Patrick Tang, Division Chief of Microbiology at Sidra Medicine said: “Sidra Medicine was one of the early adopters to mobilize its research and pathology functions to come up with new testing methods and utilize its teams, technologies and resources to support Qatar’s efforts to tackle COVID-19. Thanks to the dedication of our staff and the efficiency of our services, we can now provide faster results for COVID PCR tests. Our services make us not only one of the fastest private centers in Qatar, but also one of the faster services globally. We are also working closely with our partners at Hamad Medical Corporation, and the Ministry of Public Health including Ehteraz, to ensure that the entire COVID-19 testing process is an efficient as possible, no matter where you get your testing performed.”

The Pathology Department at Sidra Medicine upgraded commercially available rapid polymerase chain reaction (PCR) systems and developed an innovative strategy to increase the number of samples that can be tested each hour, while reducing the cost.

When all the laboratories in Qatar were overwhelmed with COVID-19 testing during the first wave of the pandemic, Hamad Al-Hail, a technologist in the molecular infectious disease laboratory at Sidra Medicine, proposed a strategy to pool multiple samples into a single rapid PCR test. Although this sample pooling strategy has been used routinely in Qatar as well as around the world, it has only been applied to conventional PCR tests which take about four hours to complete.

Hamad Al Hail, technologist at Sidra Medicine said: “The use of sample pooling for rapid PCR tests, which take less than one hour, was initially met with skepticism by other laboratory experts around the world, as these rapid PCR tests are very expensive and normally reserved for urgent clinical testing. However my colleague Dr. Mohammad Rubayet Hasan and I, persevered and were able to demonstrate that this method had excellent sensitivity and specificity. More importantly, it reduced the prohibitive cost of the rapid PCR test, while increasing the sample throughput and decreasing the turn-around time for each test.”

“I am proud to work at Sidra Medicine, where our ideas can be quickly translated into real-life clinical use to help in our fight against COVID-19. I am also proud of our team, who have been able to develop and adopt so many different methods and technologies throughout the pandemic,” continued Hamad.

The method developed at Sidra Medicine has been published in the peer-reviewed ‘Journal of Clinical Laboratory Analysis (JCLA)’ so that it can be shared with other institutions around the world.

Dr. Barbro Fridén, Chief Executive Officer at Sidra Medicine said: “We are honoured to play a role in keeping the people of Qatar safe as we all continue the fight against COVID-19. Last year, we developed two new COVID-19 testing methods to address the global shortages in conventional

testing kits. This new milestone, in becoming one of the fastest testing centers in Qatar, is further testament to our staff’s continuing hard work in providing scientific solutions that address health challenges across both a national and international level.”

-Ends -

For media enquiries and interviews contact: pr@sidra.org 

About Sidra Medicine

Sidra Medicine provides specialized healthcare to women, children, and young people from Qatar and around the world. Established by Qatar Foundation for Education, Science and Community Development, Sidra Medicine embraces best practice medical education, innovative biomedical and clinical research and discovery, and exceptional patient and family focused care.

Sidra Medicine provides comprehensive specialist healthcare services for children and young people, as well as maternity and gynecology care for women. Some of its unique children’s specialist services include Cardiology, Neurology, Urology and Plastics & Craniofacial Reconstruction. It is also currently the only specialist center in the country that treats and cares for pregnant women with fetal complications.

The ultramodern healthcare organization is a testament to Qatar’s pioneering spirit and sustained commitment to its human and social development.

To access Sidra Medicine services, and learn more about our contribution to global healthcare, education and research, please visit www.sidra.org 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.